Another important step toward a prophylactic vaccine against hepatitis C
- PMID: 35503709
- DOI: 10.1002/hep.32557
Another important step toward a prophylactic vaccine against hepatitis C
Comment on
-
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.Hepatology. 2022 Oct;76(4):1190-1202. doi: 10.1002/hep.32470. Epub 2022 May 19. Hepatology. 2022. PMID: 35313015 Free PMC article.
References
-
- Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, et al. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. Vaccine. 2010;28:6367–73.
-
- Page K, Melia MT, Veenhuis RT, Winter M, Rousseau KE, Massaccesi G, et al. Randomized trial of a vaccine regimen to prevent chronic HCV infection. N Engl J Med. 2021;384:541–9.
-
- Kelly C, Swadling L, Brown A, Capone S, Folgori A, Salio M, et al. Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes. Eur J Immunol. 2015;45:309–16.
-
- Thimme R. T cell immunity to hepatitis C virus: lessons for a prophylactic vaccine. J Hepatol. 2021;74:220–9.
-
- Donnison T, McGregor J, Chinnakannan S, Hutchings C, Center RJ, Poumbourios P, et al. A pan‐genotype hepatitis C virus viral vector vaccine generates T‐cells and neutralizing antibodies in mice. Hepatology. 2022;76:1190–1202.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical